自报睡眠时长与失眠症状在2型糖尿病预测中的临床效用
该队列研究基于英国生物银行数据,采用Cox比例风险模型分析自报睡眠时长和失眠症状与2型糖尿病发病风险的关联,并用Harrell C统计量和净重分类改善(NRI)评估将睡眠特征加入QDiabetes模型后的预测增益。结果显示,睡眠时长极端及偶尔或频繁失眠症状与发病风险升高相关,但加入QDiabetes风险评分后未改善2型糖尿病预测;加入多基因风险评分(PGS)仅有边际改善。
要点
- 睡眠时长极端及失眠症状与2型糖尿病发病风险升高相关。
- 将睡眠特征加入QDiabetes评分未改善2型糖尿病预测区分度与重分类。
- 加入2型糖尿病PGS对预测仅有边际改善,缺乏明确临床效用。
核心结论
- 睡眠时长和失眠症状虽与2型糖尿病风险相关,但在QDiabetes模型基础上不能改善2型糖尿病预测。
- 加入2型糖尿病PGS仅有边际预测改善,缺乏明确临床效用。
研究设计与样本
- 队列研究,使用英国生物银行数据,采用Cox比例风险模型分析自报睡眠时长和失眠症状与2型糖尿病发病风险的关联。
- 在英国生物银行及护士健康研究、护士健康研究II和卫生专业人员随访研究中探索独立重复验证。
主要发现
- 睡眠时长极端以及偶尔或频繁的失眠症状与2型糖尿病发病风险升高相关。
- 在英国生物银行和重复验证队列中,将睡眠特征加入QDiabetes风险评分未改善2型糖尿病预测。
- C统计量:单用QDiabetes为0.8933,QDiabetes+睡眠时长为0.8939,QDiabetes+失眠为0.8931,QDiabetes+睡眠特征为0.8935。
- 总NRI分别为0.08(95%CI -0.18, 0.33)、0.04(95%CI -0.08, 0.16)和0.04(95%CI -0.10, 0.18)。
- 加入PGS后:QDiabetes+PGS的C统计量为0.8945、总NRI为0.20(95%CI 0.12, 0.28);QDiabetes+PGS+睡眠特征的C统计量为0.8946、总NRI为0.18(95%CI 0.09, 0.27)。
关键数值与推荐
- C统计量:单用QDiabetes为0.8933;QDiabetes+睡眠时长为0.8939;QDiabetes+失眠为0.8931;QDiabetes+睡眠特征为0.8935。
- 总NRI:QDiabetes+睡眠时长为0.08(95%CI -0.18, 0.33);QDiabetes+失眠为0.04(95%CI -0.08, 0.16);QDiabetes+睡眠特征为0.04(95%CI -0.10, 0.18)。
- QDiabetes+PGS的C统计量为0.8945、总NRI为0.20(95%CI 0.12, 0.28);QDiabetes+PGS+睡眠特征的C统计量为0.8946、总NRI为0.18(95%CI 0.09, 0.27)。
临床怎么用
- 在2型糖尿病风险预测中,不应期待将自报睡眠时长或失眠症状加入QDiabetes模型能带来预测增益。
- 睡眠特征与2型糖尿病风险的关联提示其可作为健康宣教内容,但不作为预测模型改进依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Suboptimal sleep health is linked to higher risks for incident type 2 diabetes. We aimed to assess the clinical utility of adding self-reported sleep traits to a type 2 diabetes prediction model. METHODS: In this cohort study, we used UK Biobank data and Cox proportional hazards models to examine how self-reported sleep duration and insomnia symptoms were associated with incident type 2 diabetes risk. Harrell's C statistic and net reclassification improvement (NRI) were used to assess whether sleep traits improved the incident type 2 diabetes discrimination and predictive utility achieved using QDiabetes variables, with and without including a type 2 diabetes polygenic risk score (PGS). Independent replication was explored in the Nurses' Health Study, the Nurses' Health Study II and the Health Professionals Follow-up Study. RESULTS: Extremes of sleep duration and occasional or frequent insomnia symptoms were associated with higher risks for incident type 2 diabetes. In the UK Biobank and replication cohorts, adding sleep traits to the QDiabetes risk score did not improve type 2 diabetes prediction (C statistic: QDiabetes alone 0.8933; QDiabetes + sleep duration 0.8939; QDiabetes + insomnia 0.8931; QDiabetes + sleep traits 0.8935). The corresponding total NRI values were: 0.08 (95% CI -0.18, 0.33), 0.04 (95% CI -0.08, 0.16) and 0.04 (95% CI -0.10, 0.18). Inclusion of PGS data marginally improved the type 2 diabetes risk prediction achieved using The QDiabetes calculator, with or without the inclusion of sleep traits in the model (QDiabetes + PGS: C statistic 0.8945; total NRI 0.20 [95% CI 0.12, 0.28]; QDiabetes + PGS + sleep traits: C statistic 0.8946; total NRI 0.18 [95% CI 0.09, 0.27]). CONCLUSIONS/INTERPRETATION: While sleep duration and insomnia symptoms were associated with type 2 diabetes risk, they are not useful for improving type 2 diabetes prediction beyond QDiabetes model performance. Inclusion of a type 2 diabetes PGS marginally improved prediction but lacked clear clinical utility.
引用
- Wright AK, Huang T, Carr MJ, et al. Clinical utility of self-reported sleep duration and insomnia symptoms in type 2 diabetes prediction. Diabetologia. 2025. PMID: 40753283. doi:10.1007/s00125-025-06503-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。